[HTML][HTML] Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
EM Connor, RS Sperling, R Gelber… - … England Journal of …, 1994 - Mass Medical Soc
Background and Methods Maternal-infant transmission is the primary means by which young
children become infected with human immunodeficiency virus type 1 (HIV). We conducted …
children become infected with human immunodeficiency virus type 1 (HIV). We conducted …
[HTML][HTML] Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
RS Sperling, DE Shapiro, RW Coombs… - … England Journal of …, 1996 - Mass Medical Soc
Background and Methods A placebo-controlled trial has shown that treatment with zidovudine
reduces the rate at which human immunodeficiency virus type 1 (HIV-1) is transmitted from …
reduces the rate at which human immunodeficiency virus type 1 (HIV-1) is transmitted from …
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
…, MR Weir, A Reicin, D Shapiro, RS Sperling… - Circulation, 2001 - Am Heart Assoc
Background In comparing aspirin, nonselective nonsteroidal antiinflammatory agents (NSAIDs),
and cyclooxygenase (COX)-2 inhibitors, variation in platelet inhibitory effects exists that …
and cyclooxygenase (COX)-2 inhibitors, variation in platelet inhibitory effects exists that …
[HTML][HTML] The influence of pregnancy on systemic immunity
M Pazos, RS Sperling, TM Moran, TA Kraus - Immunologic research, 2012 - Springer
Adaptations in maternal systemic immunity are presumed to be responsible for observed
alterations in disease susceptibility and severity as pregnancy progresses. Epidemiological …
alterations in disease susceptibility and severity as pregnancy progresses. Epidemiological …
Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort
…, M Burger, A Togias, FR Witter, RS Sperling… - American journal of …, 2010 - atsjournals.org
Rationale: Stress-elicited disruption of immunity begins in utero. Objectives: Associations
among prenatal maternal stress and cord blood mononuclear cell (CBMC) cytokine responses …
among prenatal maternal stress and cord blood mononuclear cell (CBMC) cytokine responses …
[HTML][HTML] Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study
…, RS Sperling, L Kellerman, Y Lo, S Wallenstein… - Journal of clinical …, 2012 - Springer
Purpose The increased risk of morbidity and mortality from certain microbial infections and
the demonstrated improvements in the clinical course of some autoimmune diseases support …
the demonstrated improvements in the clinical course of some autoimmune diseases support …
Evidence relating bacterial vaginosis to intraamniotic infection
HM Silver, RS Sperling, PJS Clair, RS Gibbs - American journal of …, 1989 - Elsevier
We performed a two-part study to determine relationships of bacterial vaginosis and
intraamniotic infection. In the first part of the study, we determined whether bacterial vaginosis …
intraamniotic infection. In the first part of the study, we determined whether bacterial vaginosis …
Intraamniotic infection in low-hirth-weight infants
RS Sperling, E Newton, RS Gibbs - Journal of Infectious …, 1988 - academic.oup.com
Intraamniotic infection (IAI) complicating births of low-birth-weight infants (<2500 g) was
compared with IAI in births of infants weighing ⩾2500 g for differences in neonatal and maternal …
compared with IAI in births of infants weighing ⩾2500 g for differences in neonatal and maternal …
Peripheral blood cytokine profiling during pregnancy and post‐partum periods
TA Kraus, RS Sperling, SM Engel, Y Lo… - American journal of …, 2010 - Wiley Online Library
… This longitudinal study design allowed each woman’s post-partum blood draw to serve as
… This indicates that the cytokine expression profile from each patient’s visit was more similar …
… This indicates that the cytokine expression profile from each patient’s visit was more similar …
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates
…, M Gwynne, S Siminski, RS Sperling… - Journal of Infectious …, 1998 - academic.oup.com
The safety, toxicity, and pharmacokinetics of intrapartum and early newborn nevirapine were
evaluated in 17 human immunodeficiency virus type 1-infected women in labor and their …
evaluated in 17 human immunodeficiency virus type 1-infected women in labor and their …